A Goepferich
Overview
Explore the profile of A Goepferich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Pollinger K, Hennig R, Bauer S, Breunig M, Tessmar J, Buschauer A, et al.
J Nanosci Nanotechnol
. 2014 Apr;
14(5):3313-9.
PMID: 24734546
The biodistribution of nanoparticles is a major subject of current nanomedical research. To date, however, the exact investigation of nanoparticle fate in the microenvironment of a main excretory organ, the...
3.
Luschmann C, Herrmann W, Strauss O, Luschmann K, Goepferich A
Int J Pharm
. 2013 Jul;
455(1-2):331-7.
PMID: 23867983
For highly potent but poorly water-soluble drugs like cyclosporine A, the development of aqueous formulations providing an increase of corneal drug tissue levels, and thus of bioavailability, to increase patient...
4.
Zaky A, Elbakry A, Ehmer A, Breunig M, Goepferich A
J Control Release
. 2010 Jul;
147(2):202-10.
PMID: 20659511
The purpose of this study was to reveal factors that have an impact on the protein release kinetics from triglyceride microspheres prepared by spray congealing. We investigated the effect of...
5.
Appel B, Baumer J, Eyrich D, Sarhan H, Toso S, Englert C, et al.
Osteoarthritis Cartilage
. 2009 May;
17(11):1503-12.
PMID: 19470416
Objective: To investigate the effects of growth and differentiation factor-5 (GDF-5) alone or in combination with insulin on engineered cartilage from primary or expanded chondrocytes during 3-dimensional in vitro culture....
6.
Schoenhammer K, Petersen H, Guethlein F, Goepferich A
Int J Pharm
. 2009 Jan;
371(1-2):33-9.
PMID: 19135512
Injectable in situ forming depots (ISFD) that contain a peptide or a protein within a polymeric solution comprise an attractive, but challenging application system. Beyond chemical compatibility, local tolerability and...
7.
Schuessele A, Mayr H, Tessmar J, Goepferich A
J Biomed Mater Res A
. 2008 Jul;
90(4):959-71.
PMID: 18655137
The immobilization of biomolecules on biomaterial surfaces allows for the control of their localization and retention. In numerous studies, proteins have been simply adsorbed to enhance the biological performance of...
8.
Lungwitz U, Breunig M, Liebl R, Blunk T, Goepferich A
Eur J Pharm Biopharm
. 2007 Nov;
69(1):134-48.
PMID: 18042362
Targeted gene delivery relies on the development of materials that allow for the formation of small neutrally charged particles of sufficient colloidal stability preventing non-specific interactions with cells. In order...
9.
Hild W, Breunig M, Goepferich A
Eur J Pharm Biopharm
. 2007 Sep;
68(2):153-68.
PMID: 17869074
Nanoparticles emerged as promising tool in drug targeting, since, after appropriate modification, they are able to deliver their payload to specific sites, like tissues, cells, or even certain cellular organelles....
10.
Breunig M, Bauer S, Goepferich A
Eur J Pharm Biopharm
. 2007 Sep;
68(1):112-28.
PMID: 17804211
In recent years, a new generation of drugs has entered the pharmaceutical market. Some are more potent, but some are also more toxic and thus, therapeutical efficacy may be hindered,...